From viper jelly to artificial pancreas – a history of diabetes treatment
Diabetes, a pervasive lifestyle ailment with roots tracing back to ancient civilizations like India, Egypt, China, and Arabia, has captivated human understanding for centuries. Early attempts to grasp its complexities involved restrictive diets and herbal remedies, reflecting a lack of knowledge of the mechanisms underlying the disease. Remarkable milestones have marked the journey of diabetes treatment. A monumental shift occurred in 1921 when Frederick Banting and Charles Best's isolation of insulin heralded a new era in diabetes treatment, vastly enhancing patient longevity and comfort despite the initial discomfort of injections. From the groundbreaking synthesis of the insulin gene to the advent of insulin pens and analogues, each innovation has expanded therapeutic avenues for those affected. In the 21st century, medical engineering has evolved further, with technologies like continuous glucose monitoring systems and closed-loop pumps—called "artificial pancreas"—ushering in unprecedented glycemic control and quality of life for type 1 diabetes patients. For those with type 2 diabetes, the focus has shifted towards a comprehensive approach encompassing new and effective pharmacotherapy and lifestyle adjustments. Crucially, amidst the continuum of advancements, the cornerstone of diabetes management remains rooted in education and lifestyle adaptations. Regular meals, weight management, consumption of low-glycemic carbohydrates, exercises, and meticulous foot care are essential against debilitating complications. Despite historic and ongoing challenges, advances in diabetes treatment provide hope for increasingly modern therapies and outcomes, underscoring the importance of education and lifestyle changes in the fight against this chronic disease.
Authors
- Michalina Banaszak (ORCID: https://orcid.org/0000-0003-2771-0769)
- Sławomira Drzymała-Czyż (ORCID: https://orcid.org/0000-0001-8291-5439)
- Ilona Górna (ORCID: https://orcid.org/0000-0002-9652-0785)
- Juliusz Przysławski (ORCID: https://orcid.org/0000-0001-9205-2817)
Publication Details
- Journal
- Acta Poloniae Pharmaceutica - Drug Research
- Published
- 2024-12-11
- DOI
- https://doi.org/10.32383/appdr/194092
- Primary Topic
- Obesity and Health Practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00